期刊文献+

miR-125b慢病毒表达载体的构建及其对卵巢癌SKOV3细胞增殖和迁移的影响 被引量:2

Construction of Lentiviral Vector of miR-125b and the Effect of miR-125b on Cell Proliferation and Migration of Ovarian Cancer SKOV3 Cells
原文传递
导出
摘要 构建并鉴定miR-125b慢病毒过表达载体,研究miR-125b对卵巢癌细胞增殖和迁移的影响及其可能机制。将PCR扩增的miR-125b前体序列与经过酶切后的GP-Supersilencing Vector进行连接,产生miR-125b重组慢病毒表达载体。将重组慢病毒载体质粒、pGag/Pol、pRev和pVSV-G共转染293T细胞,包装产生慢病毒。使用收获的病毒颗粒感染卵巢癌SKOV3细胞,嘌呤霉素筛选稳定感染细胞株;实时荧光定量PCR(Real-time qPCR)检测miR-125b在SKVO3细胞中的表达;Western blot检测其潜在靶基因HER-2的表达;MTT实验和Transwell侵袭实验分别观察miR-125b过表达后SKOV3细胞增殖和迁移能力的改变。该研究成功构建miR-125b慢病毒过表达载体,感染卵巢癌SKOV3细胞后,能够过表达miR-125b,并抑制SKOV3细胞的增殖及迁移,降低潜在靶基因HER-2的表达。该研究证明,miR-125b能够抑制SKOV3细胞的增殖及迁移,并可能通过降低潜在靶基因HER-2的表达而实现。 We constructd the lentiviral vector expressing miR-125b and observed the effect ofmiR-125b on ovarian cancer cell proliferation and migration. The PCR amplification of miR-125b precursor sequence was linked with linearized GP-Supersilencing Vector to generate the recombinant lentiviral vector expressing miR-125b. The 293T cells were trans- fected with the plasmids of recombinant lentiviral vector, pGag/Pol, pRev and pVSV-G plasmids to package the lentivirus. SKOV3 cells were infected by obtained lentivirus and screened with puromycin. The expression of miR-125b in SKOV3 cells was detected by Real-time qPCR and the expression of potential target gene HER-2 was tested by Western blot. Cell proliferation and cell migration were assessed using the MTT assay and transwell migration assay. The results showed that the lentiviral vector expressing miR-125b was successfully constructed and achieved the over-expression of miR-125b after infected ovarian cancer SKOV3 cells. The over-expression of miR-125b inhibited cell proliferation and migration of SKOV3 cells and decreased the expression of HER-2 gene. We concluded that miR-125b could inhibit the proliferation and migration of SKOV3 cells through down-regulation of HER-2 expression.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2014年第4期483-488,共6页 Chinese Journal of Cell Biology
基金 重庆市渝中区科技计划项目(20120205)资助的课题~~
关键词 miR-125b HER-2 卵巢癌 细胞增殖 细胞迁移 miR-125b HER-2 ovarian cancer cell proliferation cell migration
  • 相关文献

参考文献16

  • 1Ambros V. The functions of animal microRNAs. Nature 2004; 431(7006): 350-5.
  • 2Khraiwesh B, Arif MA, Seumel GI, Ossowski S, Weigel D, Reski R, et al. Transcriptional control of gene expression by microR- NAs. Cell 2010; 140(1): 111-22.
  • 3刘宝瑞,谢丽.miRNA:新一代肿瘤生物标志[J].临床肿瘤学杂志,2010,15(1):1-5. 被引量:18
  • 4Lorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicmRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65(15): 7065-70.
  • 5Yi Guan, Hailan Yao, Zhihong Zheng, Guangrong Qiu, Kailai Sun. MiR-125b targets BCL3 and suppresses ovarian cancer pro- liferation. Int J Cancer 2011; 128(10): 2274-83.
  • 6Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007; 282 (2): 1479-8.
  • 7孟丽荣,鲁艳明,尚超.子宫内膜癌中microRNA-125b对HER2基因3'非翻译区的调控作用[J].现代肿瘤医学,2012,20(1):18-20. 被引量:1
  • 8Engelsen IB, Stefansson IM, Beroukhim R, Sellers WR, Mey- erson M, Akslen LA, et al. HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas. Int J Onco12008; 32(2): 307-16.
  • 9Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67(18): 8699-707.
  • 10Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. Mi- croRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008; 14(9): 2690-5.

二级参考文献38

  • 1凌斌,陈纲,祝怀平,赵卫东,王群华,张红雁,吴爱东,魏海明,田志刚.照射后NK-92细胞对人卵巢癌细胞杀伤活性的研究[J].现代妇产科进展,2004,13(4):251-254. 被引量:5
  • 2Marques FR,Fonsechi-Carvasan GA,De Angelo Andrade LA,et al.Immunohistochemical patterns for alpha-and beta-catenin,E-and N-cadherin expression in ovarian epithelial tumors[J].Gynecol Oncol,2004,94(1):16-24.
  • 3Verri E,Guglielmini P,Puntoni M,et al.HER2/neu oncoprotein overexpression in epithelial ovarian cancer:,evaluation of its prevalence and prognostic significance.Clinical study[J].Oncology,2005,68(2-3):154-161.
  • 4Wheelock M J,Johnson KR.Cadherins as modulators of cellular phenotype[J].Annu Rev Cell Dev Biol,2003,19(6):207-235.
  • 5Avizienyte E,Fincham V J,Brunton VG,et al.Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition[J].Mol Biol Cell,2004,15(6):2794-2803.
  • 6Wu C,Cipollone J,Maines-Bandiera S,et al.The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression[J].Differentiation,2008,76(2):193-205.
  • 7Frixen UH,Behrens J,Sachs M,et al.E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells[J].J Cell Biol,1991,113(1):173-185.
  • 8Piedra J,Martinez D,Castano J,et al.Regulation of beta-catenin structure and activity by tyrosine phosphorylation[J].J Biol Chem,2001,276(23):20436-20443.
  • 9Peifer M.Beta-catenin as oncogene:the smoking gun[J].Science,1997,275(5307):1752-1753.
  • 10Kildal W,Risberg B,Abeler VM,et al.beta-catenin expression,DNA ploidy and clinicopathological features in ovarian cancer:a study in 253 patients[J].Eur J Cancer,2005,41 (8):1127-1134.

共引文献18

同被引文献4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部